Coronavirus (COVID-19) updates

Check out general updates on the coronavirus (COVID-19) situation from

Teaching: Fall 2020 courses will proceed remotely!

  • Courses will be delivered via Zoom, myCourses, take-home kits, and other demonstrated interactive platforms
  • Course delivery will implement modern, evidence-based teaching techniques and technologies
  • This is a chance for students to shape their own education, and shape the future of science education at McGill

What will hands-on learning look like at McGill this fall?
Watch this video on Youtube or Facebook.

Better CRISPR Through Chemistry and Collaboration


Published: 19Dec2018

CRISPR has jumped to the forefront of gene editing, with game-changing applications like gene therapy, GMO-free designer crops, and synthetic organisms. It makes precise engineering and control of nearly any genome possible. But CRISPR is not perfect and its continued development relies on understanding and modifying the naturally occurring enzymes.

While countless CRISPR systems have been discovered, CRISPR-Cas9 is the most popular. It is composed of one Cas9 protein and two CRISPR ribonucleic acid (RNA) molecules that guide it to the DNA target for editing. Characterizing the intimate structure-activity relationship between Cas9 and it’s guide RNAs is a bottleneck for certain therapeutic applications.

The Masad Damha group, in collaboration with Keith Gagnon’s group at the Southern Illinois University School of Medicine, recently undertook an extensive investigation of the CRISPR-Cas9 structure-activity relationship using a wide array of chemical modifications to the CRISPR RNA. Biochemical rules governing the unique protein-RNA partnership were uncovered, including the “what,” “why” and “where” of chemical modification compatibility. These results establish guidelines for chemical modification for a broad set of applications and were recently published in Nucleic Acids Research.

Back to top